# Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

> **NCT01367210** · PHASE4 · TERMINATED · sponsor: **Catholic University of the Sacred Heart** · enrollment: 165 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Maraviroc, Darunavir/r
- **DRUG:** current antiretroviral therapy with 3 drugs

## Key facts

- **NCT ID:** NCT01367210
- **Lead sponsor:** Catholic University of the Sacred Heart
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 165 (ACTUAL)
- **Why stopped:** Because a higher rate of virological failures in study versus control arm.
- **Last updated:** 2016-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367210

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367210, "Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01367210. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*